178
Views
2
CrossRef citations to date
0
Altmetric
Atopic Dermatitis

Caregiver willingness to treat atopic dermatitis is not much improved by anchoring

ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon
Pages 471-474 | Received 05 Sep 2018, Accepted 25 Sep 2018, Published online: 03 Dec 2018

References

  • Baron SE, Cohen SN, Archer CB. Guidance on the diagnosis and clinical management of atopic eczema. Clin Exp Dermatol. 2012;37:7–12.
  • Williams HC. Established corticosteroid creams should be applied only once daily in patients with atopic eczema. Br Med J. 2007;334:1272.
  • Green C, Colquitt JL, Kirby J, et al. Topical corticosteroids for atopic eczema: clinical and cost effectiveness of once-daily vs. more frequent use. Br J Dermatol. 2005;152:130–141.
  • Bleehen SS, Chu AC, Hamann I, et al. Fluticasone propionate 0.05% cream in the treatment of atopic eczema: a multicentre study comparing once-daily treatment and once-daily vehicle cream application versus twice-daily treatment. Br J Dermatol. 1995;133:592–597.
  • Su JC, Kemp AS, Varigos GA, et al. Atopic eczema: its impact on the family and financial cost Atopic eczema: its impact on the family and financial cost. Arch Dis Child. 1997;76:159–162.
  • Storm A, Andersen SE, Benfeldt E, et al. One in 3 prescriptions are never redeemed: primary nonadherence in an outpatient clinic. J Am Acad Dermatol. 2008;59:27–33.
  • Krejci-Manwaring J, Tusa MG, Carroll C, et al. Stealth monitoring of adherence to topical medication: adherence is very poor in children with atopic dermatitis. J Am Acad Dermatol. 2007;56:211–216.
  • Zuberbier T, Orlow SJ, Paller AS, et al. Patient perspectives on the management of atopic dermatitis. J Allergy Clin Immunol. 2006;118:226–232.
  • Kojima R, Fujiwara T, Matsuda A, et al. Factors associated with steroid phobia in caregivers of children with atopic dermatitis. Pediatr Dermatol. 2013;30:29–35.
  • Oussedik E, Cardwell L, Patel N, et al. An anchoring-based intervention to increase patient willingness to use injectable medication in psoriasis. JAMA Dermatol. 2017;153:932–934.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.